|
Van Buchem disease type 2
|
C536527 |
|
|
dicarabrone A
|
C000601987 |
|
|
Reference Books, Medical
|
D012014 |
[Books in the field of medicine intended primarily for consultation.
] |
|
Van der Woude syndrome
|
C536528 |
|
|
dicarabrone B
|
C000601988 |
|
|
Reference Standards
|
D012015 |
[A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy.
] |
|
Van der Woude syndrome 2
|
C536529 |
|
|
perfluoromethylcyclopentane
|
C115615 |
|
|
Chromosome 18 deletion syndrome
|
C536580 |
|
|
P10 protein, Periplaneta americana
|
C115616 |
|
|
Chromosome 18 mosaic monosomy
|
C536581 |
|
|
B-90063
|
C115617 |
|
|
Alpha-ketoglutarate dehydrogenase deficiency
|
C536582 |
|
|
tetrachloropyrocatechol methyl ester
|
C115618 |
|
|
tetrachloropyrocatechol
|
C115619 |
|
|
Alpha-mannosidosis type 1
|
C536584 |
|
|
Alpha-mannosidosis, type 2
|
C536585 |
|
|
Alport syndrome, dominant type
|
C536586 |
|
|
Alport syndrome, recessive type
|
C536587 |
|
|
phthalhydrazidylazoacetylacetone
|
C115610 |
|
